AstraZeneca appoints new China head

The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Enhertu won its initial China nod in early 2023 as a treatment for previously treated HER2-positive breast cancer and later ...
AstraZeneca (AZN) announced the appointment of Iskra Reic as Executive Vice President, International with responsibility for overall strategy ...
The UK's benchmark FTSE 100 fell on Wednesday, ending a five-day winning streak, dragged by AstraZeneca's decline on target ...
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on beh ...
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At ...
The AstraZeneca PLC ADR AZN rallied 1.51% to $68.05 Tuesday, on what proved to be an all-around mixed trading session for the ...
China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance amid an ...
Once a common sight among the trees, many of Japan's bear hunters are now older, and their numbers are dwindling. As the ...